Skip to main content

Dr. Koay is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Koay's full profile

Already have an account?

  • Office

    1220 Holcombe Blvd
    Stop 97
    Houston, TX 77030
    Phone+1 817-805-2839
    Fax+1 713-745-7296

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2010 - 2014
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2009 - 2010
  • Baylor College of Medicine
    Baylor College of MedicineClass of 2009

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • TN State Medical License
    TN State Medical License 2022 - 2026
  • AZ State Medical License
    AZ State Medical License 2022 - 2025
  • MS State Medical License
    MS State Medical License 2022 - 2025
  • OK State Medical License
    OK State Medical License 2020 - 2025
  • TX State Medical License
    TX State Medical License 2014 - 2025
  • WA State Medical License
    WA State Medical License 2022 - 2025
  • American Board of Radiology Radiation Oncology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma  
    Shun Yu, Deyali Chatterjee, Rong Ye, Prajnan Das, Naveen Garg, Robert A Wolff, Huamin Wang, Eugene J Koay, Gauri R Varadhachary, Christopher H Crane, Milind Javle, Jef..., Clinical Cancer Research

Press Mentions

  • MD Anderson to Evaluate ARTIDIS’ Nanomechanical Technology for Tumor Analysis
    MD Anderson to Evaluate ARTIDIS’ Nanomechanical Technology for Tumor AnalysisOctober 3rd, 2022
  • MD Anderson and ARTIDIS Announce Strategic Alliance to Advance Nanomechanical Technology Platform for Optimizing Cancer Treatment
    MD Anderson and ARTIDIS Announce Strategic Alliance to Advance Nanomechanical Technology Platform for Optimizing Cancer TreatmentOctober 3rd, 2022
  • Nanobiotix Announces Publication of New Clinical Case Study Highlighting First Patient Experience of NBTXR3 Treatment for Pancreatic Cancer
    Nanobiotix Announces Publication of New Clinical Case Study Highlighting First Patient Experience of NBTXR3 Treatment for Pancreatic CancerFebruary 9th, 2022
  • Join now to see all